Contineum Therapeutics (CTNM) Leases (2023 - 2025)
Historic Leases for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $4.8 million.
- Contineum Therapeutics' Leases changed N/A to $4.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.8 million, marking a year-over-year change of. This contributed to the annual value of $5.5 million for FY2024, which is 66036.16% up from last year.
- According to the latest figures from Q3 2025, Contineum Therapeutics' Leases is $4.8 million.
- Over the past 5 years, Contineum Therapeutics' Leases peaked at $5.5 million during Q4 2024, and registered a low of $231000.0 during Q2 2024.
- Over the past 3 years, Contineum Therapeutics' median Leases value was $4.8 million (recorded in 2025), while the average stood at $3.1 million.
- Per our database at Business Quant, Contineum Therapeutics' Leases skyrocketed by 66036.16% in 2024 and then surged by 206753.25% in 2025.
- Over the past 3 years, Contineum Therapeutics' Leases (Quarter) stood at $719000.0 in 2023, then soared by 660.36% to $5.5 million in 2024, then dropped by 12.68% to $4.8 million in 2025.
- Its last three reported values are $4.8 million in Q3 2025, $5.0 million for Q2 2025, and $5.2 million during Q1 2025.